Geopolitics & Trade

On a day of remembrance, Canada reaffirms its commitment to aviation safety, driven by past tragedies and emerging geopolitical threats.

New data on leronlimab reveals striking long-term survival signals in heavily pretreated mTNBC patients, hinting at a new way to fight the disease.

With 30 years of expertise, BRUCE Piling Equipment is meeting global demand with a new framework for site-specific deep foundation machinery.

Mayors Johnson and Frey join Robert De Niro in a live counter-event aiming to 'speak over' the SOTU, marking a new, direct form of political opposition.

With its acquisition of Turner Software, Finovifi launches FrontLine Sentry, arming community banks with real-time AI to stop check fraud at the source.

Hair Cuttery Family of Brands is rolling out amika products in 500+ salons, a strategic move to meet demand for premium, inclusive haircare for all.

As Canada launches a bold defence strategy, drone-maker Draganfly recruits a former top general to navigate the multi-billion dollar opportunity.

Despite a reported net loss, the REIT saw a 162% jump in key operational funds and a 22% surge in its senior housing portfolio's income.

A new $175M Indiana facility from a Kratos-RAFAEL venture breaks ground, aiming to fix a critical national security vulnerability in U.S. rocket motor production.

After a disastrous quarter sends shares tumbling 18%, activist investor Biglari Capital calls for the ouster of Chairman David Goebel, igniting a battle.

With its Felix AI assistant, Syncx is accelerating locums staffing with faster placements and risk assessment to combat a critical healthcare shortage.

Cricket icon Rahul Dravid and Colgate Total are reframing oral care from simple hygiene to a critical performance ritual backed by compelling science.

With a new finance chair and a renewed pact with an activist investor, the off-price retailer is doubling down on its modernization and growth strategy.

As Ranger Energy Services prepares to release its Q4 results, investors are watching closely after a tough Q3. Will the report signal recovery or continued pain?

New research reveals how clinical trial design inflates the placebo effect, offering a key to solving the 90% failure rate for anxiety and depression drugs.

Cannabis giant Green Thumb Industries expands its credit facility to $189M, signaling strong lender confidence and fueling its strategic growth ambitions.

The chemical giant's dramatic dividend cut ends a 14-year growth streak, raising questions about sector health and long-term investor returns.

The credit enhancement giant raises its quarterly payout, reflecting robust profitability, strategic growth, and strong confidence from Wall Street analysts.

The REIT is offering a high 9.75% yield for new notes, but investors who refuse the swap could see their current protections vanish. A critical choice looms.

The miner posted a $2.9B free cash flow and a record $1.8B dividend payout, fueled by high gold prices and strategic growth in its 2025 earnings.